
Artificial intelligence-enabled coronary plaque quantification for personalized risk assessment and lipid-lowering therapy: Insights from the FISH&CHIPS study✰.
AI-Driven Coronary Plaque Analysis: 19.1% Risk Reduction in CAD with Targeted LDL-C Therapy 📉💔









